Cheung P Y, Barrington K J
McGill University, Montreal, Quebec, Canada.
Crit Care. 2001;5(3):158-66. doi: 10.1186/cc1016. Epub 2001 Apr 26.
The most appropriate inotropic agent for use in the newborn is uncertain. Dopamine and epinephrine are commonly used, but have unknown effects during hypoxia and pulmonary hypertension; the effects on the splanchnic circulation, in particular, are unclear.
The effects on the systemic, pulmonary, hepatic, and mesenteric circulations of infusions of dopamine and epinephrine (adrenaline) were compared in 17 newborn piglets. Three groups [control (n = 5), dopamine (n = 6) and epinephrine (n = 6)] of fentanyl anesthetized newborn piglets were instrumented to measure cardiac index (CI), hepatic arterial and portal venous blood flow, mean systemic arterial pressure (SAP), mean pulmonary arterial pressure (PAP), and arterial, portal and mixed venous oxygen saturations. Systemic, pulmonary, and mesenteric vascular resistance indices [systemic vascular resistance index (SVRI), pulmonary vascular resistance index (PVRI), mesenteric vascular resistance index (MVRI)], and systemic and splanchnic oxygen extraction and consumption were calculated. Alveolar hypoxia was induced, with arterial oxygen saturation being maintained at 55-65%. After 1 h of stabilization during hypoxia, each animal received either dopamine or epinephrine; randomly administered doses of 2, 10, and 32 microg kg-1 min-1 and 0.2, 1.0, and 3.2 microg kg-1 min-1 respectively were infused for 1 h at each dose. Results were compared with the 1 h hypoxia values by two-way analysis of variance.
Epinephrine increased CI at all doses, with no significant effects on SAP and SVRI. Although epinephrine increased PAP at 3.2 microg kg-1min-1, it had no effect on PVRI. Dopamine had no effect on CI, SAP, and SVRI, but increased PAP at all doses and PVRI at 32 microg kg-1min-1. The SAP/PAP ratio was decreased with 32 microg kg-1min-1 dopamine, whereas epinephrine did not affect the ratio. In the mesenteric circulation, dopamine at 32 microg kg-1 min-1 increased portal venous flow and total hepatic blood flow and oxygen delivery, and decreased MVRI; epinephrine had no effect on these variables. Epinephrine increased hepatic arterial flow at 0.2 microg kg-1 min-1; dopamine had no effect on hepatic arterial flow at any dose. Despite these hemodynamic changes, there were no differences in systemic or splanchnic oxygen extraction or consumption at any dose of dopamine or epinephrine.
Epinephrine is more effective than dopamine at increasing cardiac output during hypoxia in this model. Although epinephrine preserves the SAP/PAP ratio, dopamine shows preferential pulmonary vasoconstriction, which might be detrimental if it also occurs during the management of infants with persistent fetal circulation. Dopamine, but not epinephrine, increases portal flow and total hepatic flow during hypoxia.
用于新生儿的最合适的强心剂尚不确定。多巴胺和肾上腺素是常用药物,但在缺氧和肺动脉高压期间其作用尚不清楚;尤其是对内脏循环的影响尚不明确。
比较了17头新生仔猪输注多巴胺和肾上腺素对体循环、肺循环、肝循环和肠系膜循环的影响。将三组[对照组(n = 5)、多巴胺组(n = 6)和肾上腺素组(n = 6)]经芬太尼麻醉的新生仔猪进行仪器安装,以测量心脏指数(CI)、肝动脉和门静脉血流量、平均体动脉压(SAP)、平均肺动脉压(PAP)以及动脉、门静脉和混合静脉血氧饱和度。计算体循环、肺循环和肠系膜血管阻力指数[体循环血管阻力指数(SVRI)、肺循环血管阻力指数(PVRI)、肠系膜血管阻力指数(MVRI)]以及体循环和内脏氧摄取与消耗。诱导肺泡缺氧,使动脉血氧饱和度维持在55 - 65%。在缺氧稳定1小时后,每只动物接受多巴胺或肾上腺素;分别随机给予2、10和32μg·kg-1·min-1以及0.2、1.0和3.2μg·kg-1·min-1的剂量,每个剂量输注1小时。通过双向方差分析将结果与缺氧1小时的值进行比较。
肾上腺素在所有剂量下均增加CI,对SAP和SVRI无显著影响。虽然肾上腺素在3.2μg·kg-1·min-1时增加PAP,但对PVRI无影响。多巴胺对CI、SAP和SVRI无影响,但在所有剂量下均增加PAP,在32μg·kg-1·min-1时增加PVRI。多巴胺在32μg·kg-1·min-1时降低SAP/PAP比值,而肾上腺素不影响该比值。在肠系膜循环中,32μg·kg-1·min-1的多巴胺增加门静脉血流量、肝脏总血流量和氧输送,并降低MVRI;肾上腺素对这些变量无影响。肾上腺素在0.2μg·kg-1·min-1时增加肝动脉血流量;多巴胺在任何剂量下对肝动脉血流量均无影响。尽管有这些血流动力学变化,但在任何剂量的多巴胺或肾上腺素作用下,体循环或内脏氧摄取或消耗均无差异。
在该模型中,缺氧期间肾上腺素在增加心输出量方面比多巴胺更有效。虽然肾上腺素可维持SAP/PAP比值,但多巴胺显示出优先的肺血管收缩作用,如果在持续性胎儿循环婴儿的管理中也出现这种情况,可能是有害的。多巴胺而非肾上腺素在缺氧期间增加门静脉血流量和肝脏总血流量。